Reata Pharmaceuticals (RETA) Insider Trading & Ownership Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$172.32▼$172.4650-Day Range$168.70▼$172.3652-Week Range$21.83▼$172.46Volume1.99 million shsAverage Volume1.09 million shsMarket Capitalization$6.58 billionP/E RatioN/ADividend YieldN/APrice Target$157.90 Insider TradesStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainability Reata Pharmaceuticals (NASDAQ:RETA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage26.80%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$41.29 M Get RETA Insider Trade Alerts Want to know when executives and insiders are buying or selling Reata Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RETA Insider Buying and Selling by Quarter Reata Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/14/2023Andrea LoewenSVPSell3,175$172.03$546,195.25 7/28/2023Dawn Carter BirInsiderSell40,000$164.54$6,581,600.00 7/28/2023Manmeet Singh SoniCFOSell75,000$164.62$12,346,500.00 7/28/2023Shamim RuffDirectorSell8,235$164.53$1,354,904.55 6/14/2023Bhaskar AnandCAOSell2,343$102.11$239,243.73 6/13/2023Manmeet Singh SoniCFOSell78,085$102.89$8,034,165.65 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/15/2023Andrea LoewenSVPSell103$84.71$8,725.13 5/15/2023Manmeet Singh SoniCFOSell21,507$84.56$1,818,631.92 5/15/2023Michael D WortleyInsiderSell894$84.81$75,820.14 5/12/2023Andrea LoewenSVPSell6,750$86.26$582,255.00 3/10/2023Shamim RuffDirectorSell5,740$83.73$480,610.20 3/7/2023Andrea LoewenSVPSell19,036$83.43$1,588,173.48 3/7/2023Bhaskar AnandCAOSell165$84.58$13,955.70 3/6/2023Dawn Carter BirInsiderSell54,954$89.56$4,921,680.24 3/3/2023Bhaskar AnandCAOSell820$87.47$71,725.40 3/3/2023Dawn Carter BirInsiderSell2,166$88.25$191,149.50 3/3/2023Manmeet Singh SoniCFOSell3,587$87.97$315,548.39 3/2/2023Samina KhanSVPSell25,000$84.88$2,122,000.00 (Data available from 1/1/2013 forward) RETA Insider Trading Activity - Frequently Asked Questions Who is on Reata Pharmaceuticals's Insider Roster? The list of insiders at Reata Pharmaceuticals includes Andrea Loewen, Bhaskar Anand, Colin John Meyer, Dawn Carter Bir, Elaine Castellanos, Manmeet Singh Soni, Michael D Wortley, Samina Khan, and Shamim Ruff. Learn more on insiders at RETA. What percentage of Reata Pharmaceuticals stock is owned by insiders? 26.80% of Reata Pharmaceuticals stock is owned by insiders. Learn more on RETA's insider holdings. Which Reata Pharmaceuticals insiders have been selling company stock? The following insiders have sold RETA shares in the last 24 months: Andrea Loewen ($2,725,348.86), Bhaskar Anand ($324,924.83), Dawn Carter Bir ($11,694,429.74), Manmeet Singh Soni ($22,514,845.96), Michael D Wortley ($75,820.14), Samina Khan ($2,122,000.00), and Shamim Ruff ($1,835,514.75). How much insider selling is happening at Reata Pharmaceuticals? Insiders have sold a total of 347,560 Reata Pharmaceuticals shares in the last 24 months for a total of $41,292,884.28 sold. More Insider Trading Tools from MarketBeat Related Companies: GRFS Insider Trading IONS Insider Trading KRTX Insider Trading CTLT Insider Trading JAZZ Insider Trading ELAN Insider Trading ROIV Insider Trading ITCI Insider Trading APLS Insider Trading SRPT Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The most active insider sales: Stocks to put on your radarChoose these agricultural stocks to finish the year strongFeel like buying the dip on Best Buy? Your gut may be rightThe top 3 stocks insiders are selling, but you shouldn’tSimon Property Group's 7.2% Dividend Has Insiders Buying In Bulk This page (NASDAQ:RETA) was last updated on 12/5/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reata Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.